Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

March 2019
Venue TBC,

Translating the Human Microbiome into Commercially Viable Medicines

Industry Insights. Regulatory Feedback. Innovative Solutions

Webinars On Demand

WEBINAR: The Commercial Considerations of Microbiome-Based Therapeutics

The advent of microbiome-based therapeutics will offer physicians and  their patients novel treatment options. They will be very different in  their composition when compared to current therapies that are all based  on small and large molecules.

This webinar explores what might be the regulatory considerations,  customer expectations, messaging implications, and other factors  involved in launching these therapeutics.

What are the key issues that commercial teams (marketing, market  research, sales, managed care, etc.) will need to address to ensure that the therapeutic promise of these agents translates into commercial success?

Presented by JP Benya, Vice President, Commercial at Assembly Biosciences

WEBINAR: Solving the Metagenome Assembly Problem with Hi-C

Chromosome Conformation Capture tools like Hi-C directly indicate which  DNA sequences originated from the same cells in a mixed population. This enables the assembly of numerous high-quality de novo genomes (with  plasmids) without culturing from a single microbiome sample.

Phase Genomics has developed a rapid, kit-based platform that  greatly improves microbiome research efforts and shortens the path to  microbial discovery. In this webinar you will learn; How Hi-C works; How Hi-C data can be used to deconvolve metagenomes; What kinds of information you can glean from this data (case studies), and how this technology can be applied to your favorite samples.

Presented by Ivan Liachko, Co-founder & CEO at Phase Genomics 

Microbiome industry multiplication...

73%
The expected microbiome therapeutics market growth rate between 2015 and 2030
£329.7m
The expected microbiome therapeutics market value by 2025
170+
Microbiome therapeutics in early phase development